Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
Omnibus bill includes $3.1 billion for dementia research
By
Lois A. Bowers
Dec 22, 2020
The $1.4 trillion appropriations omnibus spending bill advanced by congressional leaders on Monday includes an increase of more than $300 million in funding for dementia research at the National Institutes...
91 groups, individuals praise bipartisan Alzheimer’s-related efforts in Senate
By
Lois A. Bowers
Dec 14, 2020
Twenty-seven organizations and 64 individuals told Sens. Pat Toomey (R-PA) and Debbie Stabenow (D-MI) that they are “particularly encouraged” by the lawmakers’ recommendation that the Center for...
Alzheimer’s Association releases guidance for assisted living, other providers amid coronavirus crisis
By
Lois A. Bowers
Mar 31, 2020
New guidance released Monday by the Alzheimer’s Association in collaboration with 34 long-term care industry associations and operators is designed to help ensure the delivery of high-quality care for...
Legislators scramble to clarify new dementia training requirements
By
Lois A. Bowers
Jan 07, 2020
Legislators in New Hampshire have been scrambling to clarify new minimum training requirements for workers in assisted living and other settings caring for residents with dementia after a bill with the...
‘Better business model’ needed for dementia care, Senate committee hears
By
Lois A. Bowers
Nov 21, 2019
A “better business model for the diagnosis and care of persons with Alzheimer’s disease” needs to be created, Jason Karlawish, M.D., said Wednesday at a Senate Finance Committee Subcommittee on Health...
‘Dementia-capable’ workforce a key to changing trajectory of disease: report
By
Lois A. Bowers
Oct 30, 2019
Building a “dementia-capable” workforce across the care continuum is one of five recommendations that could change the trajectory of the disease, which could affect 13 million people and lead to an...
Pharmaceutical company to pay $96 million to settle claims of promoting unapproved use of drug for dementia...
By
Lois A. Bowers
Sep 27, 2019
Pharmaceutical company Avanir has agreed to pay $96 million to resolve federal False Claims Act allegations that it paid kickbacks and marketed the drug Nuedexta in long-term care communities for the off-label...
Telemedicine decreases ED use by senior living residents with dementia: study
By
Lois A. Bowers
Aug 07, 2019
Use of telemedicine can decrease emergency department use by independent living and assisted living residents for their acute illnesses, according to a study newly published in the Journal of Post-Acute...
Being social lowers dementia risk: study
By
Lois A. Bowers
Aug 06, 2019
Older and middle-aged adults who are socially active appear to be at lower risk of developing dementia, according to new research.